EIT Health
Tolremo is based in Switzerland.
TOLREMO wants to make personalised cancer therapies even more personal and thereby long-lasting. By combining classic mutational information with novel transcriptional information, defining the exact pattern of genes expressed in that particular cancer, we design and velop combination therapies that will prevent the development of drug resistance.